This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
SEE YOU NEXT YEAR: May 7-10, 2023 | In-Person + Digital
San Diego, CA, USA

Aptamer Group

Profile

Aptamer Group develops custom affinity tools for use across the life sciences, using its proprietary Optimer® platform.

Optimer binders can be used antibody alternatives to offer novel or improved solutions for therapeutics, diagnostics, bioprocessing and analytical applications. Offering full platform compatibility, tuneable binding kinetics and high stability, Optimer binders are removing the barriers to innovation in the life sciences.